Feb 26, 2021 6:07 AM
BACK TO TOP
KSE100
45,965.62
603.04
(1.33%)
ALLSHR
31,647.87
320.62
(1.02%)
KSE30
19,199.15
314.87
(1.67%)
KMI30
76,391.73
1116.11
(1.48%)
BKTi
12,792.50
221.92
(1.77%)
OGTi
13,534.08
108.12
(0.81%)
KMIALLSHR
22,974.06
278.01
(1.22%)
UPP9
12,689.07
216.90
(1.74%)
NITPGI
9,550.45
132.64
(1.41%)
NBPPGI
11,383.32
235.39
(2.11%)
MZNPI
11,149.46
182.10
(1.66%)
GlaxoSmithKline Consumer Healthcare
PHARMACEUTICALS
Rs.268.46
1.15
(0.43%)
1D
1M
6M
YTD
1Y
3Y
5Y
As of Thu, Feb 25, 2021 3:34 PM
REG
FUT
ODL
Open
270.00
High
271.00
Low
268.00
Volume
13,300
CIRCUIT BREAKER
247.26 — 287.36
DAY RANGE
268.00 — 271.00
52-WEEK RANGE
189.00 — 337.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
LDCP
267.31
VAR
14.00
HAIRCUT
25.00
P/E Ratio (TTM)
23.30
1-Year Change *
22.86%
YTD Change *
1.26%
Open
275.00
High
275.00
Low
270.00
Close
270.00
Change
0.10%
LDCP
0.00
Volume
12
Total Trades
2
CIRCUIT BREAKER
240.58 — 294.04
DAY RANGE
270.00 — 275.00
Ask Price
278.00
Ask Volume
9
Bid Price
263.03
Bid Volume
13
Market data powered by capitalstake.com. Provided by PSX.* Returns not adjusted for payouts

Company Profile

BUSINESS DESCRIPTION

GlaxoSmithKline Consumer Healthcare Pakistan Limited was incorporated in Pakistan as a public unlisted company under the provisions of the repealed Companies Ordinance, 1984 (now Companies Act, 2017). The Company is a subsidiary of GlaxoSmithKline Consumer Healthcare B.V. The ultimate parent of the Company is GlaxoSmithKline plc, UK. The Company is engaged in manufacturing, marketing and sale of consumer healthcare products.

KEY PEOPLE
Mr. Sohail MatinCEO
Mr. M.Z. Moin MohajirChairman
Ms. Mashal MohammadCompany Secretary
ADDRESS

35 – Dockyard Road, West Wharf, Karachi – 74000

WEBSITE

www.pk-consumerhealthcare.gsk.com

REGISTRAR

CDC Share Registrar Services Limited

AUDITOR

Deloitte Yousuf Adil Chartered Accountants

Fiscal Year End

December

Equity Profile

Market Cap (000's)
31,424,453.22
Shares
117,054,508
Free Float
15,530,930
Free Float
13.27%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Oct 29, 2020Transmission of Quarterly Report for the Period Ended 30 September 2020 View   PDF
Oct 27, 2020Financial Results for the Quarter Ended 2020-09-30 View   PDF
Aug 31, 2020Transmission of Quarterly Report for the Period Ended 30-06-2020 View   PDF
Aug 28, 2020Transmission of Quarterly Report for the Period Ended 30-06-2020
REVOKED
View   PDF
Aug 26, 2020Financial Results for the Quarter Ended - 2020-06-30 View   PDF
Apr 29, 2020AUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DEC 2019 View   PDF
Apr 21, 2020GSKCH | GlaxoSmithKline Consumer Healthcare Pakistan Limited - GRANT OF EXTENSION FOR FILLING OF FINANCIAL STATEMENTS FOR THE QUARTER ENDED MARCH 31, 2020. (Q1) PDF
Oct 30, 2019Transmission of Quarterly Report for the Period Ended 2019-09-30 View   PDF
Oct 25, 2019Financial Results for the Quarter Ended 30 September 2019 View   PDF
Aug 29, 2019Transmission of Quarterly Report for the Period Ended June 30, 2019 View   PDF
DateTitleDocument
Oct 20, 2020Board Meeting View   PDF
Aug 19, 2020Board Meeting View   PDF
May 13, 2020Board Meeting Notice & Closed Period View   PDF
Apr 29, 2020NOTICE OF ANNUAL GENERAL MEETING 2019 View   PDF
Mar 25, 2020GSKCH | GlaxoSmithKline Consumer Healthcare Pakistan Limited - Postponement of Annual General Meeting PDF
Mar 6, 2020Board Meeting View   PDF
Mar 5, 2020Board Meeting
REVOKED
View   PDF
Oct 18, 2019Board Meeting View   PDF
Aug 20, 2019Board of Directors Meeting View   PDF
Jun 21, 2019Board Meeting Other than Financial Results View   PDF
DateTitleDocument
Feb 8, 2021Material Information View   PDF
Feb 4, 2021Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   PDF
Feb 1, 2021Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   PDF
Feb 1, 2021Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations
REVOKED
View   PDF
Dec 21, 2020Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   PDF
Dec 16, 2020Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   PDF
Dec 9, 2020Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   PDF
Dec 4, 2020Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   PDF
Nov 26, 2020Corporate Briefing Session View   PDF
Oct 27, 2020Appointment of Non-Executive Director View   PDF

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2019201820172016
Sales16,316,74514,875,2688,298,1425,375,805
Profit after Taxation1,257,5191,074,553706,815545,467
EPS10.749.187.397.60
Q3 2020Q2 2020Q1 2020Q3 2019
Sales5,281,0714,900,3274,308,0553,913,657
Profit after Taxation295,959382,937300,661279,525
EPS2.533.272.572.39
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2019201820172016
Gross Profit Margin (%)30.5629.1837.3728.07
Net Profit Margin (%)7.717.228.5210.15
EPS Growth (%)16.9924.22(2.76)
PEG1.401.20(15.75)

Payouts

DateFinancial ResultsDetailsBook Closure
March 12, 2020 6:23 PM31/12/2019(YR) 50%(F) (D) 14/05/2020 - 20/05/2020
March 18, 2019 5:17 PM31/12/2018(YR) 50%(F) (D) 18/04/2019 - 23/04/2019
January 29, 2018 3:23 PM31/12/2017(YR) 50% (D) 23/03/2018 - 29/03/2018

Financial Reports